Tag
Analyst Ratings
3 articles
Ginkgo Bioworks (DNA) at $7.06: Why Earnings Collapse Doesn't Tell the Full Story
DNA shares rose 1 percent as Wall Street braces for a 47 percent revenue miss this quarter—but improving unit economics and autonomous lab milestones suggest the market is pricing in worse
Airbnb Targets Rise to $175 After Strong Q2; Analysts Split on Upside
Jefferies and BMO Capital raised price targets on ABNB after second-quarter revenue climbed 16.5 percent year-over-year to $3.61 billion
AECOM Target Cut to $95 by National Bank, Consensus Still Sees 30 Percent Upside
National Bank of Canada trimmed its AECOM price target to $95 from $103, but 14 of 16 covering analysts still rate the stock a Buy.